Previous 10 | Next 10 |
2023-05-29 05:36:15 ET Summary Amgen's stock has seen a further pullback since it announced an acquisition of Horizon Therapeutics in December. Shares are down by nearly a quarter as the re-rating starts to look interesting with fundamental valuations starting to provide support. ...
2023-05-24 05:15:00 ET The Federal Trade Commission (FTC) has been taking a much more adversarial approach to mergers and acquisitions lately. For instance, it recently said it plans to block the pending deal between pharmaceutical companies Horizon Therapeutics (NASDAQ: HZNP) and ...
2023-05-23 12:38:56 ET The Federal Trade Commission lawsuit to block Amgen's ( NASDAQ: AMGN ) planned purchase of Horizon Therapeutics ( NASDAQ: HZNP ) is set for a hearing on Sept. 11. The trial date was set at a case management hearing in front of U.S. District Judge...
-- Phase 2 results for dazodalibep in Sjögren’s syndrome to be presented on June 1, 11:35-11:45 a.m. CEST and June 3, 9:35-9:45 a.m. CEST -- -- Planned presentations illustrate Horizon’s momentum in raising standards of care for rheumatology conditions inclu...
2023-05-21 07:32:58 ET Summary Shares of antibody therapy concern Viridian Therapeutics, Inc. are off some 40% since setting an all-time high of $39.00 in January following a positive readout on lead candidate VRDN-001. Despite pivotal trial data not due until mid- and late 2024, ...
2023-05-18 09:25:44 ET Amgen ( NASDAQ: AMGN ) agreed not close its $28 billion purchase of Horizon Therapeutics ( NASDAQ: HZNP ) before Sept. 15 or the second business day after the court rules on the Federal Trade Commissions' request to block the deal. Horiz...
2023-05-17 10:42:12 ET Regeneron ( NASDAQ: REGN ) CEO Leonard Schleifer said he agrees with the Federal Trade Commission's lawsuit objecting to Amgen's ( NASDAQ: AMGN ) acquisition of Horizon Therapeutics ( NASDAQ: HZNP ). Speaking at a Financial Times ph...
2023-05-17 10:41:26 ET Horizon Therapeutics ( NASDAQ: HZNP ) rose 3.2% at least partly amid some speculation that Amgen ( NASDAQ: AMGN ) could reach a settlement with the Federal Trade Commission in its suit to block the $28 billion deal. There's an idea that there c...
2023-05-17 05:13:00 ET Deal or no deal? That's now the big question for investors concerning Amgen 's (NASDAQ: AMGN) pending $28 billion acquisition of Horizon Therapeutics (NASDAQ: HZNP) . The Federal Trade Commission (FTC) announced on Tuesday that it has filed a lawsu...
2023-05-17 00:19:41 ET Summary Soros' 13F portfolio value decreased from $7.26B to $6.49B this quarter. The number of positions decreased from 208 to 185. Soros increased Horizon Therapeutics and Splunk while decreasing Rivian, Amazon, Alphabet, and First Horizon. Horizon Ther...
News, Short Squeeze, Breakout and More Instantly...
Horizon Therapeutics Public Limited Company Company Name:
HZNP Stock Symbol:
NASDAQ Market:
Horizon Therapeutics Public Limited Company Website:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Horizon Therapeutics Public Limited Company (HZNP) is expected to report $1.22 for Q3 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOM...